Titlebook: Reviews on New Drug Targets in Age-Related Disorders; Part II Paul C. Guest Book 2021 The Editor(s) (if applicable) and The Author(s), unde

只看該作者 · 發(fā)表于 2025-3-25 21:31:35

Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders,l fluid (CSF) or blood of patients. These studies have identified possible therapeutic targets and disease biomarkers. Further studies including target validation, the use of large sample sizes, and the integration of omics findings with bioinformatics tools are required to provide a better comprehension of pharmacological targets.

只看該作者 · 發(fā)表于 2025-3-26 03:47:10

只看該作者 · 發(fā)表于 2025-3-26 07:08:10

只看該作者 · 發(fā)表于 2025-3-26 10:53:00

,Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer’s Disearapy. Currently, nano-based therapies can make a difference, providing new therapeutic options by helping drugs to cross the blood-brain barrier and enter the brain more effectively. The main aim of this review was to highlight advances in research on the development of nano-based therapeutics for improved treatment of AD.

只看該作者 · 發(fā)表于 2025-3-26 15:41:12

只看該作者 · 發(fā)表于 2025-3-26 17:14:32

Paul C. GuestDescribes potential novel drug targets for age-related disorders.Reviews studies and current research on age-related disorders worldwide.Discusses developments for new therapeutic approaches to age-re

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 13:09
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved